Technology Review - Published By MIT
Advertisement

TR Editors' blog

Insights, opinions, and our editors' analysis of the latest in emerging technologies.

Blog Topics

Recent Posts

Recent Comments

  • ... : I am very excited about this project, and can foresee the day when we might be able to harness...
  • ... : I believe the same is said for the human brain. There is no information completely beyond recall,...
  • ... : Very cool.  I think it's interesting how in trying to program effective AI we seem to end up...
  • SirLanse : Getting the government to give you cash is not capitalism.  The complaint is that the chinese...
  • justme : I wiped out the flu with high daily doses of Vitamin D.  First day the congestion markedly...
  • UgoSugo : All the China-US thing has nothing to do with bloody environmentalists or corrupted politicians...
  • gabrielg01 : If solar cells become a commodity, then it's far better to let the Chinese do it. Low wages,...
  • msmsimon : The E.coli strain used in our research is non-pathogenic and of Biosafety Level 1 ("work...
  • xyzt : Now that Multitouch is realized this is the next concept from Minority Report that is being...
  • ... : I struggle to see the point of offshoring the manufacturing to cheap labour markets.  You might...
Advertisement
Tuesday, July 07, 2009

Doping Hormone Erythropoietin Also Boosts Brainpower

The red-blood-cell-boosting hormone is already used to treat anemia and by some athletes to boost endurance.
By Emily Singer

The red-blood-cell-boosting hormone erythropoietin (EPO), which is used clinically to treat anemia and illegally by athletes to boost endurance, may also improve brainpower. According to research published in the journal BMC Biology, mice treated with the drug performed better in certain learning and memory tests than did control animals.

EPO is popular among dopers because it increases blood oxygenation, mimicking the effect of blood doping. But it also targets the nervous system, improving survival of brain cells. The drug is currently in clinical trials for traumatic brain injury and stroke. (A previous post describes how EPO blocks brain swelling after trauma.)

The new research looks at how the drug affects a healthy brain. According to a press release issued by the journal,

[Hannelore] Ehrenreich [from the Max Planck Institute of Experimental Medicine, in Göttingen, Germany] and her colleagues tested the effects of erythropoietin on the ability of the mice to learn how to exploit an experimental set-up to receive sugared water. Over a series of learning stages, the mice were trained to get their treat by poking their noses into holes lit by LEDs, rather than into unlit holes, within a time limit. The mice that had been treated with recombinant human erythropoietin were significantly more likely to master the task than those that had not. According to Ehrenreich, "Treated mice showed superior performance in associative, operant and discriminant learning as well as in the initial training phases. Moreover, erythropoietin-treated mice demonstrated better task adaptation and higher performance stability."

The researchers conclude, "Further untangling of molecular mechanisms of erythropoietin action on higher cognitive functions may ultimately open new avenues for prevention strategies and therapeutic interventions in neuropsychiatric diseases."

Advertisement
Thursday, January 08, 2009

Dope Test Before Drug Is Tested in Humans

Scientists are creating anti-doping tests earlier and earlier in drug development.
By Emily Singer

Some athletes and trainers are tuned in to the drug-development pipeline, looking for the next big doping agent: experimental drugs that can boost strength and endurance but are new enough to slip under the screening radar. One scientist I spoke to for a previous piece on doping said that he still gets flooded with calls from athletes years after publishing details of a promising advance in drug development for muscular dystrophy.

In an effort to combat the abuse of new compounds before it starts, anti-doping agencies have begun working with drug companies to develop screening tests before drugs are even on the market. In last year's Tour de France, the World Anti-Doping Agency caught several cyclists using a longer-lasting form of the endurance booster EPO (erythropoietin), called CERA. Soon after the athletes were caught, it was revealed that the agency had been working with Swiss drugmaker Roche to develop a test to detect CERA while the drug was still being tested by the U.S. pharmaceutical company Amgen.

Now German scientists announce that they have developed a test for a class of compounds called benzothiazepines, which are being developed for the treatment of heart abnormalities and have been shown to boost endurance in mice. According to a press release from Drug Testing and Analysis, the journal publishing the research,

These compounds stabilize protein channels that would otherwise "leak" calcium from muscle cells during strenuous exercise. Calcium is needed for muscle contraction and this "leaking" effect weakens the contractions and is a causal factor in muscle fatigue.

While the drugs have not yet been tested in humans, researchers say that they carry a high potential for abuse because they are easy to make.

"As soon as these drugs enter human clinical trials, there is a huge potential for them to be misused in sports. This preventive research lets us prepare before these compounds are officially launched," says Mario Thevis, Director of the Center for Preventive Doping Research at the German Sport University of Cologne, Germany, who led the research.

The study characterises the compounds according to their weight and molecular structure. This gives the researchers a molecular "fingerprint" by which to identify the compounds. Thevis and colleagues show that, using high resolution mass spectrometry, JTV-519 and S-107 can be detected in spiked urine at concentrations as low as 0.1 nanograms per millilitre.

Advertisement
Advertisement

Log In

Forgot your password?     Register »
Advertisement
Technology Review November/December 2009

Current Issue

Natural Gas Changes the Energy Map
The United States has vast supplies of this cleaner fossil fuel. But how should we use it?
•  Subscribe
Save 36%
•  Table of Contents
•  MIT News
» Gift Subscription
» Digital Subscription
» Reprints, Back Issues
» Subscribe
» Table of Contents
» MIT News

More Technology News from Forbes

Advertisement
MIT Massachusetts Institute of Technology © 2009 Technology Review. All Rights Reserved.